This announcement is a separate document:
アステラス製薬：ゾルベツキシマブ FDA が承認再申請を受理
Astellas Pharma: FDA accepts re-application for approval of zolbetuximab
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.